Home » Topics » BioWorld Science

BioWorld Science
RSS

Brain activity predicts SSRI success

Oct. 1, 2019

New variants in VPS13C gene tied to reduced risk of Parkinson's disease

Sep. 30, 2019

FDA approves Rituxan for pediatric granulomatosis with polyangiitis and microscopic polyangiitis

Sep. 30, 2019

Safety characterization of a sapM mutated-BCG vaccine

Sep. 30, 2019

New TRPC5 modulators patented by Goldfinch Biopharma

Sep. 30, 2019

Novel near-infrared probe of biliary anatomy for image-guided hepatic surgery

Sep. 30, 2019

Bristol-Myers Squibb synthesizes hSTING agonists

Sep. 30, 2019

Development and characterization of IRAK-4 inhibitors

Sep. 30, 2019

Southwest Research Institute patent details agents for filovirus infection

Sep. 30, 2019

Medivir discloses nucleoside analogues for leukemia

Sep. 30, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...